Coherus Biosciences(CH:8C5)
CH:8C5
Coherus Biosciences earnings date
Coherus Biosciences (8C5) Q2 2021 Earnings Report
0 Followers
CH:8C5 Q2 2021 EPS Results
- Actual EPS
- -CHF 0.34
- Consensus EPS
- -CHF 0.18
- Beat/Miss
- Missed by -CHF 0.16
- One Year Ago EPS
- CHF 0.59
CH:8C5 Q2 2021 Revenue Results
- Actual Revenue
- CHF 73.69M
- Expected Revenue
- CHF 73.18M
- Beat/Miss
- Beat by +CHF 504.45K
- YoY Revenue Growth
- -35.40%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/05/2021
- Time
- After Close
- Conference Call
- Thursday, August 5, 2021
CH:8C5 Upcoming Earnings
Coherus Biosciences's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:8C5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -0.16- | -0.33 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.18-0.21 | -0.26 | 19.35% (+0.05) | |
| Aug 05, 2026 | 2026 (Q2) | -0.21-0.18 | -0.33 | 43.59% (+0.14) | |
| May 11, 2026 | 2026 (Q1) | -0.18-0.23 | -0.34 | 34.15% (+0.12) | |
| Mar 09, 2026 | 2025 (Q4) | -0.30-0.33 | -0.37 | 11.36% (+0.04) | |
| Nov 06, 2025 | 2025 (Q3) | -0.30-0.26 | -0.08 | -244.44% (-0.18) | |
| Aug 07, 2025 | 2025 (Q2) | -0.18-0.33 | -0.09 | -254.55% (-0.24) | |
| May 12, 2025 | 2025 (Q1) | -0.25-0.34 | 0.7 | -149.40% (-1.04) | |
| Mar 10, 2025 | 2024 (Q4) | -0.26-0.37 | -0.6 | 38.03% (+0.23) | |
| Nov 06, 2024 | 2024 (Q3) | -0.14-0.08 | -0.34 | 78.05% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

